Analyst Consensus ?
ConsensusHold35 ratings
Bullish822.8%
Neutral2468.6%
Bearish38.6%
FN2 Earnings Intelligence
The Hershey Company (HSY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 16, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 5, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Aug 21, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 22, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 25, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 4, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Jefferies | Neutral | Neutral | Maintain | Feb 2, 2026 |
| Goldman Sachs | Buy | Sell | Upgrade | Sep 16, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| Bernstein | Market Perform | Outperform | Downgrade | Oct 7, 2024 |
| Argus Research | Hold | Buy | Downgrade | Aug 14, 2024 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Mar 26, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 3, 2023 |
| Cowen & Co. | Perform | Market Perform | Maintain | Sep 14, 2022 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 29, 2022 |
| CFRA | Sell | Hold | Downgrade | Apr 23, 2020 |
| Edward Jones | Buy | Hold | Upgrade | Mar 25, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 20, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 26, 2019 |
| Piper Jaffray | Underweight | Neutral | Downgrade | Jun 20, 2019 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 25, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Jul 27, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Berenberg | Hold | Sell | Upgrade | Dec 18, 2017 |
| Societe Generale | Hold | Sell | Upgrade | Feb 28, 2017 |
| Tigress Financial | Neutral | Buy | Downgrade | Jul 11, 2016 |
| Nomura | Sell | Reduce | Maintain | Apr 20, 2015 |
Upside is calculated against the persisted current price $163.85. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $178 | $168.68 | +8.6% | Oct 16, 2026 |
| UBS | Analyst unavailable | $178 | $167.92 | +8.6% | Oct 15, 2026 |
| Jefferies | Scott Marks | $178 | $163.05 | +8.6% | Oct 14, 2026 |
| RBC Capital | Analyst unavailable | $206 | $187.84 | +25.7% | Aug 21, 2026 |
| Barclays | Analyst unavailable | $200 | $175.05 | +22.1% | Aug 3, 2026 |
| Bernstein | Alexia Howard | $201 | $174.83 | +22.7% | Jul 31, 2026 |
| D.A. Davidson | Analyst unavailable | $190 | $174.91 | +16.0% | Jul 31, 2026 |
| Deutsche Bank | Analyst unavailable | $191 | $177.2 | +16.6% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $190 | $177.23 | +16.0% | Jul 31, 2026 |
| Evercore ISI | Analyst unavailable | $225 | $170.25 | +37.3% | Jul 23, 2026 |
| Barclays | Andrew Lazar | $208 | $171.7 | +26.9% | Jul 21, 2026 |
| Jefferies | Analyst unavailable | $190 | $170.27 | +16.0% | Jul 16, 2026 |
| Piper Sandler | Analyst unavailable | $200 | $174.41 | +22.1% | Jul 9, 2026 |
| Evercore ISI | Analyst unavailable | $255 | $191.12 | +55.6% | May 27, 2026 |
| Mizuho Securities | John Baumgartner | $185 | $192.8 | +12.9% | May 20, 2026 |
| D.A. Davidson | Analyst unavailable | $208 | $181.92 | +26.9% | May 4, 2026 |
| Barclays | Analyst unavailable | $220 | $182.34 | +34.3% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $240 | $182.34 | +46.5% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $227 | $188.65 | +38.5% | Apr 23, 2026 |
| Stifel Nicolaus | Matthew Smith | $215 | $191.45 | +31.2% | Apr 21, 2026 |
| Barclays | Analyst unavailable | $225 | $197.93 | +37.3% | Apr 14, 2026 |
| Piper Sandler | Michael Lavery | $249 | $226.94 | +52.0% | Feb 25, 2026 |
| Mizuho Securities | Analyst unavailable | $195 | $226.07 | +19.0% | Feb 24, 2026 |
| Stephens | Analyst unavailable | $260 | $230.61 | +58.7% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $238 | $230.12 | +45.3% | Feb 6, 2026 |
| D.A. Davidson | Brian Holland | $243 | $230.2 | +48.3% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $267 | $231.42 | +63.0% | Feb 6, 2026 |
| Bernstein | Alexia Howard | $250 | $230.98 | +52.6% | Feb 6, 2026 |
| Evercore ISI | David Palmer | $250 | $232.75 | +52.6% | Feb 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $230 | $224.38 | +40.4% | Feb 6, 2026 |
| UBS | Analyst unavailable | $236 | $224.38 | +44.0% | Feb 6, 2026 |
| Barclays | Andrew Lazar | $240 | $224.38 | +46.5% | Feb 6, 2026 |
| D.A. Davidson | Analyst unavailable | $207 | $194.84 | +26.3% | Feb 2, 2026 |
| Deutsche Bank | Analyst unavailable | $188 | $194.54 | +14.7% | Jan 29, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $214 | $190.67 | +30.6% | Jan 28, 2026 |
| Bernstein | Alexia Howard | $84 | $189.2 | -48.7% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $210 | $198.36 | +28.2% | Jan 16, 2026 |
| UBS | Analyst unavailable | $210 | $195.73 | +28.2% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $213 | $179.28 | +30.0% | Jan 6, 2026 |
| Wells Fargo | Chris Carey | $182 | $182.41 | +11.1% | Jan 5, 2026 |
| Piper Sandler | Analyst unavailable | $193 | $188.16 | +17.8% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $211 | $181.83 | +28.8% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $180.98 | +19.0% | Dec 4, 2025 |
| Jefferies | Analyst unavailable | $181 | $180.63 | +10.5% | Dec 4, 2025 |
| Piper Sandler | Michael Lavery | $180 | $182.66 | +9.9% | Nov 21, 2025 |
| Barclays | Andrew Lazar | $188 | $169.63 | +14.7% | Nov 3, 2025 |
| Evercore ISI | David Palmer | $215 | $167.89 | +31.2% | Oct 31, 2025 |
| Morgan Stanley | Megan Alexander Clapp | $184 | $168.3 | +12.3% | Oct 31, 2025 |
| Stifel Nicolaus | Matthew Smith | $185 | $167.17 | +12.9% | Oct 31, 2025 |
| UBS | Analyst unavailable | $190 | $169.35 | +16.0% | Oct 31, 2025 |
| Stifel Nicolaus | Analyst unavailable | $195 | $181.38 | +19.0% | Oct 24, 2025 |
| Morgan Stanley | Analyst unavailable | $193 | $193.02 | +17.8% | Oct 16, 2025 |
| UBS | Analyst unavailable | $205 | $194.39 | +25.1% | Oct 8, 2025 |
| Goldman Sachs | Leah Jordan | $222 | $190.28 | +35.5% | Sep 16, 2025 |
| Piper Sandler | Michael Lavery | $167 | $187.83 | +1.9% | Sep 9, 2025 |
| D.A. Davidson | Analyst unavailable | $188 | $190.41 | +14.7% | Aug 4, 2025 |
| Piper Sandler | Michael Lavery | $168 | $175.67 | +2.5% | Nov 8, 2024 |
| Stifel Nicolaus | Matthew Smith | $180 | $179.69 | +9.9% | Nov 7, 2024 |
| Piper Sandler | Michael Lavery | $165 | $183.47 | +0.7% | Oct 23, 2024 |
| CFRA | Arun Sundaram | $169 | $183.47 | +3.1% | Oct 22, 2024 |
| Redburn Partners | Bingqing Zhu | $165 | $184.67 | +0.7% | Oct 22, 2024 |
| Jefferies | Rob Dickerson | $163 | $191 | -0.5% | Sep 26, 2024 |
| Barclays | Andrew Lazar | $202 | $195.14 | +23.3% | Sep 24, 2024 |
| Piper Sandler | Michael Lavery | $179 | $201.31 | +9.2% | Sep 17, 2024 |
| Wells Fargo | Chris Carey | $205 | $197.92 | +25.1% | May 6, 2024 |
| Coker Palmer | Thomas Palmer | $204 | $197.92 | +24.5% | May 5, 2024 |
| Wells Fargo | Chris Carey | $200 | $183.31 | +22.1% | Apr 17, 2024 |
| Deutsche Bank | Steve Powers | $197 | $194.19 | +20.2% | Apr 8, 2024 |
| Bernstein | Alexia Howard | $235 | $191.96 | +43.4% | Jan 29, 2024 |
| Morgan Stanley | Pamela Kaufman | $246 | $243.66 | +50.1% | Mar 20, 2023 |
| Craig-Hallum | Anthony Stoss | $129.11 | $233.86 | -21.2% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $230 | $233.05 | +40.4% | Feb 3, 2023 |
| Credit Suisse | Analyst unavailable | $260 | $234.77 | +58.7% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $220 | $227.7 | +34.3% | Jan 3, 2023 |
| Morgan Stanley | Pamela Kaufman | $231 | $234.89 | +41.0% | Dec 20, 2022 |
| UBS | Analyst unavailable | $269 | $236.69 | +64.2% | Dec 8, 2022 |
| Deutsche Bank | Analyst unavailable | $246 | $232.4 | +50.1% | Dec 6, 2022 |
| BNP Paribas | Analyst unavailable | $235 | $218.12 | +43.4% | Nov 15, 2022 |
| Mizuho Securities | Analyst unavailable | $210 | $227.48 | +28.2% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $222 | $227.2 | +35.5% | Apr 29, 2022 |
| BMO Capital | Analyst unavailable | $255 | $227.48 | +55.6% | Apr 29, 2022 |
| Credit Suisse | Robert Moskow | $227 | $201.88 | +38.5% | Feb 4, 2022 |
| Bank of America Securities | Bryan Spillane | $225 | $201.88 | +37.3% | Feb 4, 2022 |
| Piper Sandler | Michael Lavery | $205 | $203.01 | +25.1% | Feb 3, 2022 |
| Goldman Sachs | Jason English | $227 | $203.01 | +38.5% | Feb 3, 2022 |
| Mizuho Securities | John Baumgartner | $196 | $203.01 | +19.6% | Feb 3, 2022 |
| Morgan Stanley | Pamela Kaufman | $191 | $193.17 | +16.6% | Jan 11, 2022 |
Track every rating change on HSY the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.